Patent classifications
A23L29/045
Microparticles for encapsulating probiotics, obtaining said microparticles and uses thereof
The invention relates to self-assembling microparticles comprising a solid matrix and probiotic bacteria, wherein the solid matrix comprises soybean protein and a divalent or trivalent metal, and wherein the probiotic bacteria are distributed throughout the solid matrix; said matrix protects said probiotic bacteria during processing, storage, as well as during transit through the gastrointestinal tract, thus prolonging their lifetime and facilitating release into the intestine and improving their probiotic effect. The present invention also relates to the method for obtaining the self-assembling microparticles and to the products and compositions incorporating them.
COMPOUNDS FOR TREATING ALZHEIMER'S DISEASE
The present invention relates to a compound of the following formula (I): (I) or a pharmaceutically acceptable salt or hydrate thereof, for use in the prevention or treatment of Alzheimer's disease in an individual.
##STR00001##
ORAL USE OF CORIANDER SEED OIL FOR A SOOTHING EFFECT ON REACTIVE SKIN
An oil from seeds of at least one umbelliferous plant, coriander, in ingestible form for preventing or slowing the appearance of dysesthetic sensations on sensitive human skin.
PHARMACEUTICAL COMPOSITION, FOOD COMPOSITION AND FOOD ADDITIVE FOR PREVENTING, ALLEVIATING OR TREATING MUSCLE LOSS, WEAKNESS AND ATROPHY, CONTAINING, AS ACTIVE INGREDIENT, ENTEROCOCCUS FAECALIS, CULTURE LIQUID THEREOF OR DEAD CELLS THEREOF
The present invention relates to a pharmaceutical composition, a food composition, and a food additive for the prevention and treatment or improvement of muscle loss, muscle weakness, and muscle atrophy, which contain Enterococcus faecalis, particularly Enterococcus faecalis EF-2001 among others, a culture solution thereof, or a killed body thereof as an active ingredient. Killed Enterococcus faecalis EF-2001 of the present invention exhibits a remarkable treatment effect for muscle loss, muscle weakness, and muscle atrophy by inhibiting the damage to muscle cells induced by oxidative stress, and thus killed lactic acid bacterium Enterococcus faecalis EF-2001 of the present invention or a culture solution thereof can be usefully used as an active ingredient in a pharmaceutical composition, a food composition, and a food additive for prevention of muscle atrophy and sarcopenia.
LOW-CALORIE HERBAL ENERGY DRINK
The present disclosure is drawn to a low-calorie, low caffeine herbal energy drink for enhancing mood and well-being comprising an infusion of Schisandra berries, coffee beans, fenugreek seed, Cardamom seed and supplemented with a natural sweetener, such as maple syrup. The energy drink does not contain any artificial flavors, sweeteners or preservatives.
Consumable Product Comprising Malted Dehulled Oats
The disclosure relates to a consumable product comprising malted dehulled oats and/or a leachate of malted dehulled oat, wherein said consumable product induces endogenous production of antisecretory factor (AF) protein and/or fragments thereof in a subject after consumption. The malted dehulled oats comprised in the consumable product disclosed herein is produced by a novel malting process.
The malted dehulled oats and/or a leachate of malted dehulled oats comprised in the consumable product comprises (i) avenanthramide D, wherein the concentration of (i) is higher as compared to the corresponding non-malted dehulled oats, and optionally one or more of the compounds selected from the group consisting of (ii) avenanthramide A, (iii) avenathramide C, (iv) avenanthramide C methyl ester, (v) (Z)-N-feruloyl 5-hydroxyanthranilic acid, (vi) avenanthramide G, and (vii) a compound selected from the group consisting of guaiacol or a derivative thereof, L-tryptophan , DL-phenylalanine, and any combination thereof, wherein the concentration of one or more of (ii-vii) is higher as compared to in the corresponding non-malted dehulled oats.
The disclosure further provides use of the consumable product as food or feed for humans and/or animals, as well as for medical use.
Consumable Product Comprising Malted Wheat
The disclosure relates to a consumable product comprising malted wheat and/or a leachate of malted wheat, wherein said consumable product induces endogenous production of antisecretory factor (AF) protein and/or fragments thereof in a subject after consumption. The malted wheat of the consumable product comprises (i) 2-methoxyphenol and/or a derivate thereof, and (ii) 2,4-dihydroxy-7-methoxy-(2)-1,4-benzoxazin-3(4H)-one derivative, wherein (a) the concentration of (i) is higher and/or substantially the same as compared to the corresponding non-malted wheat, and (b) the concentration of (ii) is higher as compared to the corresponding non-malted wheat.
The present disclosure further relates to a consumable product produced in accordance with the herein described process, and to use of the consumable product as food or feed for humans and/or animals as well as for medical uses.
Composition remedy to prevent symptoms related to excessive alcohol consumption
An edible composition to increase the metabolism of alcohol thus prevent or lessen the symptoms caused by ingesting excessive amounts of alcohol is disclosed.
COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS
The present invention relates to a pharmaceutical composition for preventing or treating hair loss, a health functional food composition or a cosmetic composition, including a specific compound or a pharmaceutically acceptable salt thereof as an active ingredient, wherein the compound exhibits an excellent hair growth recovery effect in hair follicle tissues in which hair growth is inhibited without cytotoxicity, and thus hair loss can be more effectively prevented, improved, or treated.
COMPOSITION REMEDY TO PREVENT SYMPTOMS RELATED TO EXCESSIVE ALCOHOL CONSUMPTION
An edible composition to increase the metabolism of alcohol thus prevent or lessen the symptoms caused by ingesting excessive amounts of alcohol is disclosed.